{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T07:09:14Z","timestamp":1795244954774,"version":"4.10.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS132836"],"award-info":[{"award-number":["NS132836"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62482-7","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T03:02:46Z","timestamp":1754103766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Sporadic ALS induced pluripotent stem cell derived neurons reveal hallmarks of TDP-43 loss of function"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2001-8470","authenticated-orcid":false,"given":"Jeffrey D.","family":"Rothstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Keeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Warlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-5170","authenticated-orcid":false,"given":"Cindy V.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-4971","authenticated-orcid":false,"given":"Jonathan D.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-5325","authenticated-orcid":false,"given":"Alyssa N.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"62482_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","volume":"7","author":"PM Andersen","year":"2011","unstructured":"Andersen, P. M. & Al-Chalabi, A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nat. Rev. Neurol. 7, 603\u2013615 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"62482_CR2","doi-asserted-by":"publisher","unstructured":"Ghasemi, M. & Brown, R. H., Jr. Genetics of amyotrophic lateral sclerosis. Cold Spring Harb. Perspect. Med. 8. https:\/\/doi.org\/10.1101\/cshperspect.a024125 (2018).","DOI":"10.1101\/cshperspect.a024125"},{"key":"62482_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40142-020-00194-8","volume":"8","author":"JM Gregory","year":"2020","unstructured":"Gregory, J. M., Fagegaltier, D., Phatnani, H. & Harms, M. B. Genetics of Amyotrophic Lateral Sclerosis. Curr. Genet. Med. Rep. 8, 121\u2013131 (2020).","journal-title":"Curr. Genet. Med. Rep."},{"key":"62482_CR4","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Prim. 3, 17071 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"62482_CR5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori, P. & Van Damme, P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 27, 1918\u20131929 (2020).","journal-title":"Eur. J. Neurol."},{"key":"62482_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrn3430","volume":"14","author":"W Robberecht","year":"2013","unstructured":"Robberecht, W. & Philips, T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248\u2013264 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"62482_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"62482_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.21154","volume":"61","author":"C Amador-Ortiz","year":"2007","unstructured":"Amador-Ortiz, C. et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease. Ann. Neurol. 61, 435\u2013445 (2007).","journal-title":"Ann. Neurol."},{"key":"62482_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nrneurol.2010.18","volume":"6","author":"AS Chen-Plotkin","year":"2010","unstructured":"Chen-Plotkin, A. S., Lee, V. M. & Trojanowski, J. Q. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 6, 211\u2013220 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"62482_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ de Boer","year":"2020","unstructured":"de Boer, E. M. J. et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 92, 86\u201395 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"62482_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00415-009-5069-7","volume":"256","author":"F Geser","year":"2009","unstructured":"Geser, F., Martinez-Lage, M., Kwong, L. K., Lee, V. M. & Trojanowski, J. Q. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J. Neurol. 256, 1205\u20131214 (2009).","journal-title":"J. Neurol."},{"key":"62482_CR12","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/ijms10010232","volume":"10","author":"M Neumann","year":"2009","unstructured":"Neumann, M. Molecular neuropathology of TDP-43 proteinopathies. Int. J. Mol. Sci. 10, 232\u2013246 (2009).","journal-title":"Int. J. Mol. Sci."},{"key":"62482_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs, K. A. et al. TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol. 127, 811\u2013824 (2014).","journal-title":"Acta Neuropathol."},{"key":"62482_CR14","doi-asserted-by":"publisher","first-page":"fcz014","DOI":"10.1093\/braincomms\/fcz014","volume":"1","author":"SM Lee","year":"2019","unstructured":"Lee, S. M. et al. TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis\/frontotemporal lobar degeneration. Brain Commun. 1, fcz014 (2019).","journal-title":"Brain Commun."},{"key":"62482_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-018-1942-8","volume":"137","author":"AL Nana","year":"2019","unstructured":"Nana, A. L. et al. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology. Acta Neuropathol. 137, 27\u201346 (2019).","journal-title":"Acta Neuropathol."},{"key":"62482_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/17482961003602363","volume":"11","author":"A Bodansky","year":"2010","unstructured":"Bodansky, A. et al. TDP-43 and ubiquitinated cytoplasmic aggregates in sporadic ALS are low frequency and widely distributed in the lower motor neuron columns independent of disease spread. Amyotroph. Lateral Scler. 11, 321\u2013327 (2010).","journal-title":"Amyotroph. Lateral Scler."},{"key":"62482_CR17","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1093\/brain\/aww250","volume":"139","author":"SC Vatsavayai","year":"2016","unstructured":"Vatsavayai, S. C. et al. Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain139, 3202\u20133216 (2016).","journal-title":"Brain"},{"key":"62482_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00401-023-02653-2","volume":"147","author":"K Chang","year":"2023","unstructured":"Chang, K. et al. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer\u2019s disease neuropathologic changes and cognitive decline. Acta Neuropathol. 147, 4 (2023).","journal-title":"Acta Neuropathol."},{"key":"62482_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/nan.12148","volume":"40","author":"JR Highley","year":"2014","unstructured":"Highley, J. R. et al. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones. Neuropathol. Appl. Neurobiol. 40, 670\u2013685 (2014).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"62482_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim, J. R. et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167\u2013179 (2019).","journal-title":"Nat. Neurosci."},{"key":"62482_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","volume":"603","author":"AL Brown","year":"2022","unstructured":"Brown, A. L. et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603, 131\u2013137 (2022).","journal-title":"Nature"},{"key":"62482_CR22","doi-asserted-by":"crossref","unstructured":"Irwin, K. E. et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD. Nat Med. 30, 382\u2013393 (2024).","DOI":"10.1038\/s41591-023-02788-5"},{"key":"62482_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma, X. R. et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature 603, 124\u2013130 (2022).","journal-title":"Nature"},{"key":"62482_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed, Z. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180\u2013190 (2019).","journal-title":"Nat. Neurosci."},{"key":"62482_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nn.2779","volume":"14","author":"M Polymenidou","year":"2011","unstructured":"Polymenidou, M. et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459\u2013468 (2011).","journal-title":"Nat. Neurosci."},{"key":"62482_CR26","doi-asserted-by":"crossref","unstructured":"Seddighi, S. et al. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD. Sci Transl Med. 16, eadg7162 (2024).","DOI":"10.1126\/scitranslmed.adg7162"},{"key":"62482_CR27","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling, J. P., Pletnikova, O., Troncoso, J. C. & Wong, P. C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650\u2013655 (2015).","journal-title":"Science"},{"key":"62482_CR28","doi-asserted-by":"publisher","unstructured":"Prudencio, M. et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Investig. https:\/\/doi.org\/10.1172\/jci139741 (2020).","DOI":"10.1172\/jci139741"},{"key":"62482_CR29","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn, M. W. et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science379, 1140\u20131149 (2023).","journal-title":"Science"},{"key":"62482_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41593-021-01006-0","volume":"25","author":"EG Baxi","year":"2022","unstructured":"Baxi, E. G. et al. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nat. Neurosci. 25, 226\u2013237 (2022).","journal-title":"Nat. Neurosci."},{"key":"62482_CR31","doi-asserted-by":"publisher","unstructured":"Baskerville, V., Rapuri, S., Mehlhop, E. & Coyne, A. N. SUN1 facilitates CHMP7 nuclear influx and injury cascades in sporadic amyotrophic lateral sclerosis. Brain. https:\/\/doi.org\/10.1093\/brain\/awad291 (2023).","DOI":"10.1093\/brain\/awad291"},{"key":"62482_CR32","doi-asserted-by":"publisher","unstructured":"Coyne, A. N. et al. G(4)C(2) Repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS\/FTD. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2020.06.027 (2020).","DOI":"10.1016\/j.neuron.2020.06.027"},{"key":"62482_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling, S. C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416\u2013438 (2013).","journal-title":"Neuron"},{"key":"62482_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie, I. R. et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427\u2013434 (2007).","journal-title":"Ann. Neurol."},{"key":"62482_CR35","doi-asserted-by":"publisher","first-page":"114421","DOI":"10.1016\/j.celrep.2024.114421","volume":"43","author":"WP Huang","year":"2024","unstructured":"Huang, W. P. et al. Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion. Cell Rep. 43, 114421 (2024).","journal-title":"Cell Rep."},{"key":"62482_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00401-024-02705-1","volume":"147","author":"H Spence","year":"2024","unstructured":"Spence, H. et al. RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS. Acta Neuropathol. 147, 50 (2024).","journal-title":"Acta Neuropathol."},{"key":"62482_CR37","doi-asserted-by":"publisher","unstructured":"Coyne, A. N. et al. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med. 13. https:\/\/doi.org\/10.1126\/scitranslmed.abe1923 (2021).","DOI":"10.1126\/scitranslmed.abe1923"},{"key":"62482_CR38","doi-asserted-by":"publisher","unstructured":"Thaller, D. J. et al. An ESCRT-LEM protein surveillance system is poised to directly monitor the nuclear envelope and nuclear transport system. eLife 8. https:\/\/doi.org\/10.7554\/eLife.45284 (2019).","DOI":"10.7554\/eLife.45284"},{"key":"62482_CR39","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.15252\/embj.201694574","volume":"35","author":"BM Webster","year":"2016","unstructured":"Webster, B. M. et al. Chm7 and Heh1 collaborate to link nuclear pore complex quality control with nuclear envelope sealing. EMBO J. 35, 2447\u20132467 (2016).","journal-title":"EMBO J."},{"key":"62482_CR40","doi-asserted-by":"publisher","first-page":"E2166","DOI":"10.1073\/pnas.1613916114","volume":"114","author":"M Gu","year":"2017","unstructured":"Gu, M. et al. LEM2 recruits CHMP7 for ESCRT-mediated nuclear envelope closure in fission yeast and human cells. Proc. Natl. Acad. Sci. USA 114, E2166\u2013e2175 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62482_CR41","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.cub.2016.07.039","volume":"26","author":"Y Olmos","year":"2016","unstructured":"Olmos, Y., Perdrix-Rosell, A. & Carlton, J. G. Membrane binding by CHMP7 coordinates ESCRT-III-dependent nuclear envelope reformation. Curr. Biol.: CB 26, 2635\u20132641 (2016).","journal-title":"Curr. Biol.: CB"},{"key":"62482_CR42","doi-asserted-by":"publisher","unstructured":"Gatta, A. T. et al. CDK1 controls CHMP7-dependent nuclear envelope reformation. eLife 10. https:\/\/doi.org\/10.7554\/eLife.59999 (2021).","DOI":"10.7554\/eLife.59999"},{"key":"62482_CR43","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.cell.2017.10.033","volume":"171","author":"D Clift","year":"2017","unstructured":"Clift, D. et al. A method for the acute and rapid degradation of endogenous proteins. Cell 171, 1692\u20131706.e1618 (2017).","journal-title":"Cell"},{"key":"62482_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature14973","volume":"525","author":"K Zhang","year":"2015","unstructured":"Zhang, K. et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56\u201361 (2015).","journal-title":"Nature"},{"key":"62482_CR45","doi-asserted-by":"crossref","unstructured":"Seddighi, S. et al. Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS\/FTD. Sci. Transl. Med. eadg7162, (2024).","DOI":"10.1126\/scitranslmed.adg7162"},{"key":"62482_CR46","doi-asserted-by":"publisher","unstructured":"Irwin, K. E. et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-023-02788-5 (2024).","DOI":"10.1038\/s41591-023-02788-5"},{"key":"62482_CR47","doi-asserted-by":"publisher","first-page":"15962","DOI":"10.1523\/JNEUROSCI.2526-14.2014","volume":"34","author":"AN Coyne","year":"2014","unstructured":"Coyne, A. N. et al. Futsch\/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J. Neurosci. 34, 15962\u201315974 (2014).","journal-title":"J. Neurosci."},{"key":"62482_CR48","first-page":"6886","volume":"24","author":"AN Coyne","year":"2015","unstructured":"Coyne, A. N. et al. Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation. Hum. Mol. Genet. 24, 6886\u20136898 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"62482_CR49","doi-asserted-by":"publisher","first-page":"e3002028","DOI":"10.1371\/journal.pbio.3002028","volume":"21","author":"Y Koike","year":"2023","unstructured":"Koike, Y. et al. TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS\/FTD risk gene, UNC13A. PLoS Biol. 21, e3002028 (2023).","journal-title":"PLoS Biol."},{"key":"62482_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4161\/rna.7.4.12205","volume":"7","author":"E Buratti","year":"2010","unstructured":"Buratti, E. & Baralle, F. E. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 7, 420\u2013429 (2010).","journal-title":"RNA Biol."},{"key":"62482_CR51","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.molmed.2011.06.004","volume":"17","author":"TJ Cohen","year":"2011","unstructured":"Cohen, T. J., Lee, V. M. & Trojanowski, J. Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 17, 659\u2013667 (2011).","journal-title":"Trends Mol. Med."},{"key":"62482_CR52","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1093\/hmg\/ddt349","volume":"22","author":"J Janssens","year":"2013","unstructured":"Janssens, J. & Van Broeckhoven, C. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum. Mol. Genet. 22, R77\u2013R87 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"62482_CR53","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","volume":"19","author":"C Lagier-Tourenne","year":"2010","unstructured":"Lagier-Tourenne, C., Polymenidou, M. & Cleveland, D. W. TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46\u2013R64 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"62482_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrm.2016.147","volume":"18","author":"M Beck","year":"2017","unstructured":"Beck, M. & Hurt, E. The nuclear pore complex: understanding its function through structural insight. Nat. Rev. Mol. Cell Biol. 18, 73\u201389 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62482_CR55","doi-asserted-by":"publisher","unstructured":"Lin, D. H. & Hoelz, A. The structure of the nuclear pore complex (An Update). Ann. Rev. Biochem. https:\/\/doi.org\/10.1146\/annurev-biochem-062917-011901 (2019).","DOI":"10.1146\/annurev-biochem-062917-011901"},{"key":"62482_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ceb.2019.04.001","volume":"58","author":"P Pascual-Garcia","year":"2019","unstructured":"Pascual-Garcia, P. & Capelson, M. Nuclear pores in genome architecture and enhancer function. Curr. Opin. Cell Biol. 58, 126\u2013133 (2019).","journal-title":"Curr. Opin. Cell Biol."},{"key":"62482_CR57","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nrm3461","volume":"13","author":"M Raices","year":"2012","unstructured":"Raices, M. & D\u2019Angelo, M. A. Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions. Nat. Rev. Mol. cell Biol. 13, 687\u2013699 (2012).","journal-title":"Nat. Rev. Mol. cell Biol."},{"key":"62482_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ceb.2016.12.006","volume":"46","author":"M Raices","year":"2017","unstructured":"Raices, M. & D\u2019Angelo, M. A. Nuclear pore complexes and regulation of gene expression. Curr. Opin. cell Biol. 46, 26\u201332 (2017).","journal-title":"Curr. Opin. cell Biol."},{"key":"62482_CR59","doi-asserted-by":"publisher","unstructured":"Roczniak-Ferguson, A. & Ferguson, S. M. Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis. Life Sci Alliance 2, https:\/\/doi.org\/10.26508\/lsa.201900358 (2019).","DOI":"10.26508\/lsa.201900358"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62482-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62482-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62482-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:14:25Z","timestamp":1757337265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62482-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62482"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62482-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.N.C. (50%) and J.D.R. (50%) are inventors on US patent application number 63\/111,882 filed by Johns Hopkins University on methods to modulate CHMP7 expression as a therapy for neurodegeneration. A.N.C. (75%) and J.D.R. (25%) are inventors on US patent application number 63\/605,054 filed by Johns Hopkins University on methods to increase\/restore expression of POM121 for mitigation of NPC injury and TDP-43 dysfunction in neurodegeneration. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7092"}}